Aktis Oncology, Inc.
AKTS
$25.00
$0.281.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | -24.14M | -18.33M | -15.14M | -18.08M | |
| Total Depreciation and Amortization | 879.00K | 652.00K | 695.00K | 552.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 2.19M | 2.49M | 393.00K | 202.00K | |
| Change in Net Operating Assets | 489.00K | -9.06M | -1.19M | 1.14M | |
| Cash from Operations | -20.59M | -24.24M | -15.24M | -16.18M | |
| Capital Expenditure | -1.26M | -1.85M | -4.15M | -1.54M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -267.45M | 22.40M | -122.30M | 69.68M | |
| Cash from Investing | -268.71M | 20.54M | -126.46M | 68.15M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 156.00K | 339.81M | 258.00K | 0.00 | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 0.00 | -2.26M | -1.03M | 0.00 | |
| Cash from Financing | 156.00K | 337.55M | -772.00K | 0.00 | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -289.14M | 333.85M | -142.47M | 51.97M | |